Your browser doesn't support javascript.
loading
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.
Bradley, John S; Stone, Gregory G; Chan, Phylinda L S; Raber, Susan R; Riccobene, Todd; Mas Casullo, Veronica; Yan, Jean Li; Hendrick, Victoria M; Hammond, Jennifer; Leister-Tebbe, Heidi K.
Afiliação
  • Bradley JS; From the Department of Pediatrics, Rady Children's Hospital/University of California San Diego School of Medicine, San Diego, California.
  • Stone GG; Microbiology, Internal Medicine, Pfizer, Groton, Connecticut.
  • Chan PLS; Clinical Pharmacology, Pfizer, Sandwich, Kent, United Kingdom.
  • Raber SR; Clinical Pharmacology, Pfizer, La Jolla, California.
  • Riccobene T; Clinical Pharmacology, Allergan plc, Madison, New Jersey.
  • Mas Casullo V; Clinical Pharmacology, Allergan plc, Madison, New Jersey.
  • Yan JL; Biostatistics, Pfizer, New York, New York.
  • Hendrick VM; Clinical Pharmacology, Pfizer, Sandwich, Kent, United Kingdom.
  • Hammond J; Global Medical Affairs, Pfizer, Collegeville, Pennsylvania.
  • Leister-Tebbe HK; Global Medical Affairs, Pfizer, Collegeville, Pennsylvania.
Pediatr Infect Dis J ; 39(5): 411-418, 2020 05.
Article em En | MEDLINE | ID: mdl-32091493

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Sepse Neonatal / Antibacterianos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Sepse Neonatal / Antibacterianos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article